DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection
- PMID: 7884923
- PMCID: PMC188955
- DOI: 10.1128/JVI.69.4.2684-2688.1995
DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection
Abstract
DNA vaccination has been evaluated with the lymphocytic choriomeningitis virus (LCMV) model system. Plasmid DNA encoding the LCMV nucleoprotein, when injected intramuscularly, induces both antiviral antibodies and cytotoxic T lymphocytes. Injection of DNA encoding the nucleoprotein or the viral glycoprotein confers protection against normally lethal LCMV challenge in a major histocompatibility complex-dependent manner. The protection conferred is incomplete, but it is most probably mediated by the induced cytotoxic T lymphocytes.
Similar articles
-
Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge.J Virol. 1997 Oct;71(10):7881-8. doi: 10.1128/JVI.71.10.7881-7888.1997. J Virol. 1997. PMID: 9311877 Free PMC article.
-
Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.Eur J Immunol. 1989 Mar;19(3):417-24. doi: 10.1002/eji.1830190302. Eur J Immunol. 1989. PMID: 2468501
-
Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.J Virol. 1994 Jun;68(6):3486-90. doi: 10.1128/JVI.68.6.3486-3490.1994. J Virol. 1994. PMID: 7514676 Free PMC article.
-
Principles of cytotoxic T lymphocyte induction and recognition.Curr Top Microbiol Immunol. 1995;202:247-59. doi: 10.1007/978-3-642-79657-9_16. Curr Top Microbiol Immunol. 1995. PMID: 7587366 Review. No abstract available.
-
Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model.Immunogenetics. 2001 Apr;53(3):185-9. doi: 10.1007/s002510100314. Immunogenetics. 2001. PMID: 11398962 Review.
Cited by
-
Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines.J Virol. 2002 Dec;76(23):11911-9. doi: 10.1128/jvi.76.23.11911-11919.2002. J Virol. 2002. PMID: 12414933 Free PMC article.
-
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.J Exp Med. 2008 Mar 17;205(3):533-41. doi: 10.1084/jem.20071948. Epub 2008 Mar 10. J Exp Med. 2008. PMID: 18332180 Free PMC article.
-
DNA immunization confers protection against murine cytomegalovirus infection.J Virol. 1996 Nov;70(11):7921-8. doi: 10.1128/JVI.70.11.7921-7928.1996. J Virol. 1996. PMID: 8892915 Free PMC article.
-
CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.J Virol. 2001 Nov;75(21):10421-30. doi: 10.1128/JVI.75.21.10421-10430.2001. J Virol. 2001. PMID: 11581410 Free PMC article.
-
Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model.Vaccine. 2015 Aug 20;33(35):4313-20. doi: 10.1016/j.vaccine.2015.03.086. Epub 2015 Apr 14. Vaccine. 2015. PMID: 25887087 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources